Data completeness
2/8 — Basic
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KWELL (lindane) is a topical lotion indicated for the treatment of scabies and lice infestations. It is a small-molecule pediculicide and scabicide that works through neurotoxic mechanisms in parasites. This pre-launch product represents GSK's entry into a mature, commodity-like dermatological parasiticide market.
Pre-Launch
Pre-launch status suggests small commercial infrastructure and limited team expansion until market entry; early adopter roles in medical affairs and market access critical.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
REThinkWELL- the Use of Therapeutic Game to Reduce Mental Health Symptoms in Children and Adolescents
Started May 2021
279 enrolled
Emotional ProblemMental Health Issue
Why This Matters for Your Career
Worked on KWELL at GSK? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.